BR112012011227A2 - teobromina e agente combinado com outro antitussígeno não opióide e seu uso terapêutico - Google Patents

teobromina e agente combinado com outro antitussígeno não opióide e seu uso terapêutico

Info

Publication number
BR112012011227A2
BR112012011227A2 BR112012011227A BR112012011227A BR112012011227A2 BR 112012011227 A2 BR112012011227 A2 BR 112012011227A2 BR 112012011227 A BR112012011227 A BR 112012011227A BR 112012011227 A BR112012011227 A BR 112012011227A BR 112012011227 A2 BR112012011227 A2 BR 112012011227A2
Authority
BR
Brazil
Prior art keywords
theobromine
opioid
antitussive
therapeutic use
another non
Prior art date
Application number
BR112012011227A
Other languages
English (en)
Portuguese (pt)
Inventor
Robin Mark Bannister
John Brew
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41509324&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012011227(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of BR112012011227A2 publication Critical patent/BR112012011227A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112012011227A 2009-11-13 2010-11-12 teobromina e agente combinado com outro antitussígeno não opióide e seu uso terapêutico BR112012011227A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0919889.6A GB0919889D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy
PCT/GB2010/051895 WO2011058373A2 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy

Publications (1)

Publication Number Publication Date
BR112012011227A2 true BR112012011227A2 (pt) 2017-06-13

Family

ID=41509324

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012011227A BR112012011227A2 (pt) 2009-11-13 2010-11-12 teobromina e agente combinado com outro antitussígeno não opióide e seu uso terapêutico

Country Status (17)

Country Link
EP (1) EP2498777A2 (https=)
JP (2) JP2013510841A (https=)
CN (1) CN102753174A (https=)
AU (1) AU2010317667B2 (https=)
BR (1) BR112012011227A2 (https=)
CA (1) CA2780703A1 (https=)
CO (1) CO6551744A2 (https=)
GB (1) GB0919889D0 (https=)
IL (1) IL219768A0 (https=)
MX (1) MX2012005532A (https=)
NZ (1) NZ599949A (https=)
PE (1) PE20130147A1 (https=)
PH (1) PH12012501369A1 (https=)
RU (1) RU2519086C2 (https=)
UA (1) UA108993C2 (https=)
WO (1) WO2011058373A2 (https=)
ZA (1) ZA201204248B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US20190008850A1 (en) * 2015-12-30 2019-01-10 Paul J. Markovitz Method of treating schizophrenia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
ES2236833T3 (es) * 1996-11-25 2005-07-16 THE PROCTER & GAMBLE COMPANY Compuestos heterociclicos de guanidinilo utiles como agonistas de receptores adrenergicos alfa 2.
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US20030206942A1 (en) * 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
US6207674B1 (en) * 1999-12-22 2001-03-27 Richard A. Smith Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants
RU2350316C2 (ru) * 2003-05-29 2009-03-27 Унилевер Нв Композиция для обработки волос
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
WO2008089260A2 (en) * 2007-01-16 2008-07-24 Victory Pharma, Inc. Combined administration of benzonatate and guaifenesin

Also Published As

Publication number Publication date
GB0919889D0 (en) 2009-12-30
CO6551744A2 (es) 2012-10-31
ZA201204248B (en) 2013-02-27
JP2013510841A (ja) 2013-03-28
CN102753174A (zh) 2012-10-24
JP2016128439A (ja) 2016-07-14
RU2519086C2 (ru) 2014-06-10
CA2780703A1 (en) 2011-05-19
RU2012124038A (ru) 2013-12-20
EP2498777A2 (en) 2012-09-19
AU2010317667A1 (en) 2012-06-07
WO2011058373A2 (en) 2011-05-19
AU2010317667B2 (en) 2014-05-29
PE20130147A1 (es) 2013-03-13
NZ599949A (en) 2013-08-30
MX2012005532A (es) 2012-09-28
UA108993C2 (en) 2015-07-10
PH12012501369A1 (en) 2012-10-22
IL219768A0 (en) 2012-07-31
JP6118919B2 (ja) 2017-04-19
WO2011058373A3 (en) 2011-07-07

Similar Documents

Publication Publication Date Title
CL2008002381A1 (es) Oligonucleotido inmunoestimulador; composicion farmaceutica que lo comprende; y su uso para tratar un trastorno o afeccion en un sujeto, incluyendo cancer.
GT201300320A (es) Terapia de combinación que comprende un inhibidor de cdk4/6 y un inhibidor de pi3k para el uso en el tratamiento de cáncer.
MX2009010066A (es) Composiciones y metodos para la ablacion especifica de la evasion mutacional de terapias especificas para cancer.
BR112012011227A2 (pt) teobromina e agente combinado com outro antitussígeno não opióide e seu uso terapêutico
CL2007000876A1 (es) Uso de un antagonista del factor de crecimiento endotelial vascular (vegf) en combinacion con un segundo agente que comprende un agente reductor de celula mieloide para tratar un tumor resistente en un sujeto; y metodo de diagnostico del tumor.
CL2007003523A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer
PA8631801A1 (es) Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos
CL2008002782A1 (es) Anticuerpo anti-bv8 neutralizante; composicion que lo comprende; y su uso para tratar tumores en humanos previamente tratados con un antagonista del factor de crecimiento endotelial vascular.
WO2007100901A3 (en) Epinephrine dosing regimens
BR112012014159A8 (pt) combinações terapêuticas de teobromina e um anti-histamínico
BR112012022243A8 (pt) Uso de um inibidor de autofagia baseado em tioxantona e de um composto indutor de autofagia para terapia de câncer, composição farmacêutica e kit farmacêutico
MX2015013177A (es) Combinacion de tratamientod de cancer usando microarns e inhibidores de egfr-tki.
BR112012029844A2 (pt) uso de metamorfina em combinação com um ativador de glucoquinase e combinações compreendendo metamorfina com um ativador de glucoquinase
MX2019008817A (es) Formulacion de liberacion prolongada para reducir la frecuencia de miccion y metodo de uso de la misma.
BR112013017953A2 (pt) Composição farmacêutica, formulação tópica, método, e, composição fotossensibilizadora
PH12013500392A1 (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy
BR112012011224A2 (pt) teobromina e agente combinado com um opióide antitussígeno e seu uso terapêutico
PH12012501203A1 (en) Combination of theobromine with a decongestant and its use for the treatment of cough
ATE510594T1 (de) Hustenpräparat
AR073180A1 (es) Productos que contienen derivados de amidina con depsipeptidos ciclicos
CL2010001594A1 (es) Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida.
BR112014030570A2 (pt) extratos de tomilho selvagem e uso destes
CL2011000252A1 (es) Uso de estriol para preparar un medicamento util en la prevencion y/o el tratamiento de atrofia urogenital en mujeres.
ECSP12011969A (es) Combinaciones terapéuticas de teobromina y una antihistamina
CL2010000439A1 (es) Uso para tratar transtorno urogenital-neurologico en un mamifero de una composicion con una toxina de clostridium que comprende un dominio de union de peptido opioide, un dominio de traslocacion de la toxina de clostridium y un dominio enzimatico de la toxina de clostridium.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2493 DE 16/10/2018.

B350 Update of information on the portal [chapter 15.35 patent gazette]